You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

HomeClinical InformationPerformance MeasuresRheumatoid Arthritis

Rheumatoid Arthritis

    Do Not Support
    • Group/Practice
    • Individual Clinician

    Assessment and Classification of Disease Prognosis

    Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months.

    Date Reviewed: April 27, 2015

    Do Not Support: Uncertain Validity
    • Group/Practice
    • Individual Clinician

    Rheumatoid Arthritis (RA): Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy

    Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who are newly prescribed disease modifying anti-rheumatic drug therapy within 12 months.

    Date Reviewed: April 27, 2015

    Support
    • Group/Practice
    • Individual Clinician

    Rheumatoid Arthritis: Functional Status Assessment

    Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis for whom a functional status assessment was performed at least once during the measurement period.

    Date Reviewed: April 27, 2015

    Support
    • Group/Practice
    • Individual Clinician

    Rheumatoid Arthritis: Assessment of Disease Activity

    Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) and >=50% of total number of outpatient RA encounters in the measurement year with assessment of disease activity using a standardized measure.

    Date Reviewed: April 27, 2015

    Support
    • Group/Practice
    • Individual Clinician

    Rheumatoid Arthritis: Tuberculosis Screening

    Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who have documentation of a tuberculosis (TB) screening performed within 12 months prior to receiving a first course of therapy using a biologic disease-modifying anti-rheumatic drug (DMARD).

    Date Reviewed: April 27, 2015

    Do Not Support: Uncertain Validity
    • Health Plan
    • Integrated Delivery System

    Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy for Rheumatoid Arthritis

    The percentage of patients 18 years and older by the end of the measurement period, diagnosed with rheumatoid arthritis and who had at least one ambulatory prescription for a disease-modifying anti-rheumatic drug.

    Date Reviewed: April 27, 2015

    Do Not Support
    • Group/Practice
    • Individual Clinician

    Glucocorticoid Management

    Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >= 10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid management plan within 12 months.

    Date Reviewed: November 19, 2017

    As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!